Anti-CD49B [GBR500 (Vatelizumab, TMC-2206)], Clone: [GBR500 Vatelizumab TMC-2206], Human, Monoclonal

Produktübersicht

• Artikelname: Anti-CD49B [GBR500 (Vatelizumab, TMC-2206)], Clone: [GBR500 Vatelizumab TMC-2206], Human, Monoclonal
• Artikelnummer: ABA-AB04186-13.12
• Hersteller Artikelnummer: Ab04186-13.12
• Alternativnummer: ABA-AB04186-13.12
• Hersteller: Absolute Antibody
• Wirt: Human
• Kategorie: Antikörper
• Applikation: Blocking, ELISA, FC
• Spezies Reaktivität: Human, Primate, Rat
• Alternative Synonym: ITGA2, Integrin alpha2beta1, Integrin alpha-2/beta-1, Integrin alpha-2, CD49 antigen-like family member B, Collagen receptor, Platelet membrane glycoprotein Ia, GPIa, VLA-2 subunit alpha, BHA2.1, SAR339658

Produktbeschreibung

The parental mouse antibody was generated by immunizing BALB/c mice with human fibrosarcoma HT1080 cells. The original humanized version was generated by grafting the CDRs of murine parental antibody onto human acceptor framework regions.

Produkteigenschaften

• Klonalität: Monoclonal
• Klon-Bezeichnung: [GBR500 Vatelizumab TMC-2206]
• UniProt: P17301
• Puffer: PBS with 0.02% Proclin 300.
• Target-Kategorie: CD49B